Local and Global News
Culture Biosciences, a San Francisco-based technology company enabling biotech firms to develop manufacturing processes in the cloud, selected Scispot as its exclusive platform to automate workflows.
This licence allows PBG to diversify its GMP-compliant manufacturing business through the addition of natural health products including nutraceuticals, herbal remedies, vitamins, minerals and other non-prescription over the counter therapeutics.
BioAlberta remains opposed to both the process and content of Health Canada's PMPRB draft regulation proposals since they were first published.
CanBiocin companion animal probiotic currently undergoing European Food Safety Authority (EFSA) review
The Standard Processing Licence allows PBG to process and/or sell cannabis/hemp derived ingredients including extracts, concentrate, and isolates to other licenced partners.
Psychedelic medicine is a rapidly growing area and could be potential breakthrough therapeutics globally for psychiatric conditions such as depression, post-traumatic stress disorder (PTSD) and addiction.
48Hour Discovery Inc and RayzeBio announce research collaboration to discover and develop novel peptide-based radiopharmaceuticals to treat cancer.
FREDsense Technologies Corp. announces the closing of a Convertible Debenture valued at $2.5 million from BDC Capital's Cleantech Practice.
As part of this partnership, HelaPlex will gain access to a white label digital operating platform powered by Scispot.
The company strives to empower entrepreneurs to start and virtually run their biotech startups from garages, coffee shops, dorm rooms, or anywhere else innovation is born.
MACH32 and Andau Medical announced today that the Aerosol Containment Tent (ACT) has been successfully adopted by University Health Network in Toronto, Ontario
Firm also announces strategic partnership with Ayming Canada to help businesses maximize funding
BioAlberta has joined the national call for more collaboration to create a better environment for the development of new vaccines, meds and other health technologies in Canada.
BioAlberta believes Alberta is positioned to play a key role in enhancing domestic biomanufacturing capacity in Canada.
BioNeutra North America Inc has signed an agreement with Western Economic Diversification Canada (WD) to accelerate the company's plans to increase its capacity and enhance business development activities.
Foodbev magazine has named BioNeutra's popular sugar reduction product -- VitaFiber® IMO -- as a finalist in the World's Food Innovation Awards for 2021.
Project funded through CQDM Quantum Leap program with support from Merck and GlycoNet will exploit new drug development platform
Alberta's government is accepting proposals to understand and explore opportunities related to the province's vaccine capacity as part of a long-term strategy to enhance our vaccine manufacturing capabilities.
BioNeutra Global Corporation-maker of VitaFiber® IMO-today announced the launch of a multi-phase research project funded by three of the nation's leading research organizations to aid in the development of new better-for-you 'gut health' products.
Canadian Hospital Specialties will be the exclusive distributor of Ekobi® Embolization Microspheres in Canada.
48Hour Discovery Inc. (48HD) and Quantum Intelligence Corp. (QIC) announced today the establishment of a joint venture called Quantum Intelligence Discovery.
The Port of San Diego has approved a pilot project with FREDsense Technologies Corp. to develop a portable five-in-one field-testing sensor device to provide real-time metals analysis for stormwater monitoring.